← FDA Drug Approvals (Drugs@FDA)

PREGABALIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX INC · Approved 2014-02-21

Drug application

FDA Application #

ANDA203022

Application type

Abbreviated New Drug Application (Generic)

Brand name

PREGABALIN

Generic name

Pregabalin

Active ingredients

PREGABALIN

Dosage form

CAPSULE

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

APOTEX INC

First approval

2014-02-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown